Humana Inc. (HUM) News
Humana Inc. (HUM)
Today's Latest Price: $395.85 USD
Updated Jan 26 6:40pm
Add HUM to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 8 in Medical - Health Insurance
See all "A" rated Strong Buy stocks
StocksNews Articles for HUM
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest HUM News From Around the Web
Below are the latest news stories about Humana Inc that investors may wish to consider to help them evaluate HUM as an investment opportunity.
Monogram Health Announces Availability of Kidney Disease Care Coordination Services for Humana Members in Tennessee and AlabamaMonogram Health announced today that it is expanding its collaboration with leading health and wellness company Humana Inc. (NYSE: HUM). Through an agreement now in effect, Monogram is providing care coordination services in Alabama and Tennessee for eligible Humana Medicare Advantage and Commercial health plan members with chronic kidney disease (CKD) or End Stage Renal Disease (ESRD). This is in addition to providing such services as previously contracted with Humana in two other states, Louisiana and Mississippi. |
Partners in Primary Care Announces 2021 Growth Plans for Its Senior-Focused Care FacilitiesPartners in Primary Care announces 2021 growth plans for its senior-focused care facilities. |
Humana Names Nwando Olayiwola, M.D., Chief Health Equity OfficerLOUISVILLE, Ky.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) has named Nwando Olayiwola, M.D., MPH, FAAFP, to the position of Senior Vice President and Chief Health Equity Officer. In this newly created role, Dr. Olayiwola will report directly to Humana Chief Medical and Corporate Affairs Officer William Shrank, M.D., and will set direction and establish strategy to promote health equity across all Humana lines of business, including its care delivery assets. |
Barclays Stick to Their Buy Rating for Humana Inc By Investing.comBarclays Stick to Their Buy Rating for Humana Inc |
Humana Healthy Horizons and The Humana Foundation Commit More Than $2.5 Million to COVID-19 Relief in TexasAUSTIN, Texas--(BUSINESS WIRE)--Humana Healthy Horizons and The Humana Foundation commit more than $2.5 million to COVID-19 relief in Texas. |
4 Peter Lynch Growth Stocks With Good Financial StrengthStocks have high cash-to-debt ratios |
Billionaire Stephen Mandel’s Lone Pine Is Embracing The Tech RevolutionIn this article, we reviewed returns from billionaire Stephen Mandel’s top ten stock picks to determine whether Lone Pine’s strategy of embracing the tech revolution is working. Click to skip ahead and see Billionaire Stephen Mandel’s Top 5 Stock Picks. Julian Robertson’s protege Stephen Mandel’s hedge fund Lone Pine Capital has generated annualized returns of […] |
Use the private sector — especially insurance companies — to speed up COVID-19 vaccinesWhile the development of COVID-19 vaccines at “warp speed” has been very impressive, the continuing role of the private sector shouldn’t be forgotten as we struggle to quickly get vaccines into all those waiting arms. As a former health insurer CEO, I know insurance companies can be one key to making sure we all get our COVID shots. It’s not enough to focus on just getting vaccines out to providers or worrying about staff shortages in hospitals or paying for treatment through the CARES Act. |
athenahealth and Humana Collaborate to Improve Healthcare Outcomes for its MembersWATERTOWN, Mass. & LOUISVILLE, Ky.--(BUSINESS WIRE)--Collaboration integrates Humana’s value-added member insights within athenahealth’s EHR to support provider decision-making at point of care. |
Humana Partners with Leading Ohio Nonprofits to Address Food Insecurity and HousingCOLUMBUS, Ohio--(BUSINESS WIRE)--Humana partners with leading Ohio nonprofits to address food insecurity and housing. |